An Efficacy and Safety Study of Palovarotene for the Treatment of MO
Clinical trial NCT03442985 · TERMINATED
Trial details
- NCT number
- NCT03442985
- Sponsor
- Clementia Pharmaceuticals Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-22
- Primary completion
- 2020-03-24
- Enrollment
- 193
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.